Skip to main content

Adaptive Bayesian Design with Penalty Based on Toxicity-Efficacy Response

  • Conference paper

Part of the book series: Contributions to Statistics ((CONTRIB.STAT.))

Abstract

The penalized local D-optimal design is introduced by Dragalin and Fedorov (J. Stat. Plan. Inference 136:1800–1823, 2006). We extend the method to the Bayesian realm for the bivariate Gumbel model. Then we conduct a simulation study to compare our method with the trade-off methods of Thall and Cook (Biometrics 60:684–693, 2004). Various measures are employed to present a thorough understanding of both the methods. Our method is more favorable in terms of consistency across simulations and information gain.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Atkinson, A.C., Donev, A.N., Tobias, R.: Optimum Experimental Design, with SAS. Oxford University Press, Oxford (2007)

    Google Scholar 

  • Chaloner, K., Larntz, K.: Optimal Bayesian design applied to logistic regression experiments. J. Stat. Plan. Inference 21, 191–208 (1989)

    Article  MathSciNet  MATH  Google Scholar 

  • Dragalin, V., Fedorov, V.: Adaptive designs for dose-finding based on efficacy-toxicity response. J. Stat. Plan. Inference 136, 1800–1823 (2006)

    Article  MathSciNet  MATH  Google Scholar 

  • Haines, L.M., Perevozskaya, I., Rosenberger, W.F.: Bayesian optimal designs for phase I clinical trials. Biometrics 50, 591–600 (2003)

    Article  MathSciNet  Google Scholar 

  • Mats, V.A., Rosenberger, W.F., Flournoy, N.: Restricted optimality for phase I clinical trials. In: Flournoy, N., Rosenberger, W.F., Wong, W.K. (eds.) New Developments and Applications in Experimental Design, pp. 50–61. Institute of Mathematical Statistics, Hayward (1998)

    Chapter  Google Scholar 

  • Perevozskaya, I., Rosenberger, W.F., Haines, L.M.: Optimal design for the proportional odds model. Can. J. Stat. 31, 225–235 (2003)

    Article  MathSciNet  MATH  Google Scholar 

  • Roy, A., Ghosal, S., Rosenberger, W.F.: Convergence properties of sequential Bayesian D-optimal designs. J. Stat. Plan. Inference 139, 425–440 (2003)

    Article  MathSciNet  Google Scholar 

  • Thall, P.F., Cook, J.D.: Dose-finding based on efficacy-toxicity trade-offs. Biometrics 60, 684–693 (2004)

    Article  MathSciNet  MATH  Google Scholar 

Download references

Acknowledgements

The authors thank the referees for constructive comments. Dr. Rosenberger’s research is supported by a grant from the National Cancer Institute under the American Recovery and Reinvestment Act of 2009.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lei Gao .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer International Publishing Switzerland

About this paper

Cite this paper

Gao, L., Rosenberger, W.F. (2013). Adaptive Bayesian Design with Penalty Based on Toxicity-Efficacy Response. In: Ucinski, D., Atkinson, A., Patan, M. (eds) mODa 10 – Advances in Model-Oriented Design and Analysis. Contributions to Statistics. Springer, Heidelberg. https://doi.org/10.1007/978-3-319-00218-7_11

Download citation

Publish with us

Policies and ethics